Tango Therapeutics TNGX Income Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $6.19M+10.0% | $5.63M-2.3% | $5.76M-11.0% | $6.48M-11.4% | $7.31M-7.4% | ||
| $56.99M-8.6% | $62.38M-6.2% | $66.5M+174% | $24.3M-40.7% | $40.99M-2.6% | ||
| $129.26M-2.2% | $132.17M-1.4% | $134M-1.8% | $136.45M-4.1% | $142.3M-1.1% | ||
| $174.52M+0.5% | $173.67M-1.8% | $176.84M-2.6% | $181.58M-2.8% | $186.86M-0.4% | ||
| $10.27M+5.9% | $9.7M-2.3% | $9.93M-16.5% | $11.89M-13.9% | $13.81M-10.9% | ||
| -$107.23M-5.5% | -$101.59M-1.1% | -$100.52M+30.9% | -$145.57M-10.1% | -$132.26M-1.5% | ||
| -188.2%-25.3pp | -162.9%-11.7pp | -151.1%+448pp | -599.1%-276pp | -322.7%-12.9pp | ||
| -$115.41M-5.9% | -$109.01M-1.0% | -$107.91M+30.3% | -$154.8M-8.0% | -$143.37M-0.2% | ||
| -202.5%-27.8pp | -174.7%-12.5pp | -162.3%+475pp | -637.1%-287pp | -349.8%-9.6pp | ||
| -$117.53M-5.6% | -$111.29M-0.9% | -$110.34M+29.9% | -$157.29M-7.8% | -$145.87M-0.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Tango Therapeutics's income statement data come from?
- Every line is extracted from Tango Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.